SymbolIMCR
NameIMMUNOCORE HOLDINGS PLC
SectorHEALTH CARE
RegionEurope
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address92 PARK DRIVE,MILTON PARK, ABINGDON, OX14 4RY, United Kingdom
Telephone+44 1235438600
Fax
Email
Websitehttps://www.immunocore.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001671927
Description

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

Additional info from NASDAQ:
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

2026-05-15 18:00

New Form SCHEDULE 13G - Immunocore Holdings plc <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000902664-26-002542 <b>Size:</b> 15 KB

Read more
2026-05-08 09:18

New Form S-8 - Immunocore Holdings plc <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001140361-26-019737 <b>Size:</b> 299 KB

Read more
2026-05-06 11:09

(10% Negative) IMMUNOCORE HOLDINGS PLC (IMCR) Reports Q2 2026 Financial Results

Read more
2026-05-06 11:00

Immunocore reports first quarter financial results and provides a business update

Read more
2026-05-06 11:00

Immunocore reports first quarter financial results and provides a business update

Read more
2026-04-19 22:00

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

Read more
2026-04-19 22:00

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

Read more
2026-04-16 17:06

New Form DEF 14A - Immunocore Holdings plc <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001140361-26-015122 <b>Size:</b> 10 MB

Read more
2026-04-08 19:57

📋 David Berman (Affiliate) plans to sell 25K shares of Immunocure Holdings PLC (at $31.85 each, total $796K) Filed: Apr 08, 2026 | ID: 000149

Read more
2026-04-06 11:00

Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference

Read more